- Home
- ZURA vs PRQR Comparison
ZURA vs PRQR Comparison
Compare ZURA & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZURA
- PRQR
- Stock Information
- Founded
- ZURA 2022
- PRQR 2012
- Country
- ZURA United States
- PRQR Netherlands
- Employees
- ZURA N/A
- PRQR N/A
- Industry
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- ZURA Health Care
- PRQR Health Care
- Exchange
- ZURA Nasdaq
- PRQR Nasdaq
- Market Cap
- ZURA 292.1M
- PRQR 309.5M
- IPO Year
- ZURA N/A
- PRQR 2014
- Fundamental
- Price
- ZURA $2.28
- PRQR $2.83
- Analyst Decision
- ZURA Buy
- PRQR Strong Buy
- Analyst Count
- ZURA 6
- PRQR 5
- Target Price
- ZURA $15.80
- PRQR $7.60
- AVG Volume (30 Days)
- ZURA 456.6K
- PRQR 474.2K
- Earning Date
- ZURA 11-07-2024
- PRQR 11-07-2024
- Dividend Yield
- ZURA N/A
- PRQR N/A
- EPS Growth
- ZURA N/A
- PRQR N/A
- EPS
- ZURA N/A
- PRQR N/A
- Revenue
- ZURA N/A
- PRQR $20,506,357.00
- Revenue This Year
- ZURA N/A
- PRQR $370.31
- Revenue Next Year
- ZURA N/A
- PRQR N/A
- P/E Ratio
- ZURA N/A
- PRQR N/A
- Revenue Growth
- ZURA N/A
- PRQR 306.68
- 52 Week Low
- ZURA $2.00
- PRQR $1.61
- 52 Week High
- ZURA $6.35
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- ZURA 28.72
- PRQR 32.39
- Support Level
- ZURA $2.71
- PRQR $3.26
- Resistance Level
- ZURA $2.81
- PRQR $3.46
- Average True Range (ATR)
- ZURA 0.23
- PRQR 0.23
- MACD
- ZURA -0.02
- PRQR -0.10
- Stochastic Oscillator
- ZURA 12.62
- PRQR 1.30
About ZURA Zura Bio Limited
Zura Bio Ltd is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.